Chiesi Ventures
Boston, Massachusettschiesiventures.com
Overview
Chiesi Ventures is a venture capital firm focused on the area of rare and orphan disorders. Its goal is to complement the strategic interest of the Chiesi Group by investing in early stage development opportunities. Chiesi Ventures also aims to accelerate the expansion of the Chiesi network in the EU and the US among universities, venture capital investors, rare disease patient organizations and entrepreneurial companies developing treatments for rare diseases .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Glycomine | Apr 2025 | Series C | - |
| Minoryx Therapeutics | May 2022 | Series C | Co-investor |
| CuraSen Therapeutics, Inc. | Nov 2021 | Series A Extension | Co-investor |
| Glycomine | Jun 2021 | Series B | Co-investor |
| Glycomine | Aug 2019 | Series B | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
